Rebecca Zash

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.

Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, Patel S, Peter L, Liu J, Borducchi EN, Nkolola JP, Souza M, Tan CS, Zash R, Julg B, Nathavitharana RR, Shapiro RL, Azim AA, Alonso CD, Jaegle K, Ansel JL, Kanjilal DG, Guiney CJ, Bradshaw C, Tyler A, Makoni T, Yanosick KE, Seaman MS, Lauffenburger DA, Alter G, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H, Barouch DH.

JAMA. 2021 04 20. 325(15):1535-1544. PMID: 33704352

Adverse Birth Outcomes in Botswana Among Women With Vertically or Horizontally Acquired Human Immunodeficiency Virus.

Fennell C, Seage GR, Zash R, Phiri K, Diseko M, Mayondi G, Lockman S, Sekoto T, Mmalane M, Makhema J, Shapiro R.

J Pediatric Infect Dis Soc. 2021 Apr 03. 10(3):252-258. PMID: 32539088

Limited surface examination to evaluate potential teratogens in a resource-limited setting.

Holmes LB, Nasri HZ, Hunt AT, Zash R, Shapiro RL.

Birth Defects Res. 2021 May 15. 113(9):702-707. PMID: 33779067

Modest reduction in adverse birth outcomes following the COVID-19 lockdown.

Caniglia EC, Magosi LE, Zash R, Diseko M, Mayondi G, Mabuta J, Powis K, Dryden-Peterson S, Mosepele M, Luckett R, Makhema J, Mmalane M, Lockman S, Shapiro R.

Am J Obstet Gynecol. 2021 06. 224(6):615.e1-615.e12. PMID: 33347842

Weight gain during pregnancy among women initiating dolutegravir in Botswana.

Caniglia EC, Shapiro R, Diseko M, Wylie BJ, Zera C, Davey S, Isaacson A, Mayondi G, Mabuta J, Luckett R, Makhema J, Mmalane M, Lockman S, Zash R.

EClinicalMedicine. 2020 Dec. 29-30:100615. PMID: 33437946

Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis.

Kanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A, Ford N, Thorlund K, Anis PAH, Karim ME, Mofenson L, Zash R, Calmy A, Kredo T, Bansback N.

EClinicalMedicine. 2020 Nov. 28:100573. PMID: 33294805

Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.

Burwick RM, Yawetz S, Stephenson KE, Collier AY, Sen P, Blackburn BG, Kojic EM, Hirshberg A, Suarez JF, Sobieszczyk ME, Marks KM, Mazur S, Big C, Manuel O, Morlin G, Rose SJ, Naqvi M, Goldfarb IT, DeZure A, Telep L, Tan SK, Zhao Y, Hahambis T, Hindman J, Chokkalingam AP, Carter C, Das M, Osinusi AO, Brainard DM, Varughese TA, Kovalenko O, Sims MD, Desai S, Swamy G, Sheffield JS, Zash R, Short WR.

Clin Infect Dis. 2020 Oct 08. PMID: 33031500

A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials.

Pastick KA, Nicol MR, Smyth E, Zash R, Boulware DR, Rajasingham R, McDonald EG.

Open Forum Infect Dis. 2020 Sep. 7(9):ofaa350. PMID: 32929403

Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.

Duffy CR, Hart JM, Modest AM, Hacker MR, Golen T, Li Y, Zera C, Shainker SA, Mehrotra P, Zash R, Wylie BJ.

Obstet Gynecol. 2020 08. 136(2):229-231. PMID: 32433451

Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.

Davey S, Ajibola G, Maswabi K, Sakoi M, Bennett K, Hughes MD, Isaacson A, Diseko M, Zash R, Batlang O, Moyo S, Lockman S, Lichterfeld M, Kuritzkes DR, Makhema J, Shapiro R.

J Acquir Immune Defic Syndr. 2020 07 01. 84(3):235-241. PMID: 32195745